Illustration: Oslo Cancer Society

Raising Prostate Cancer Awareness

This week on Monday, Prostate Cancer Day, the Norwegian Cancer Society initiated their Blue-Ribbon Campaign to raise prostate cancer awareness. In line with the campaign, Oslo Cancer Cluster gives you the chance to update yourselves on prostate cancer research Thursday the 30th of November.

 

The Blue-Ribbon campaign is initially a month’s focus on prostate cancer, one of the deadliest forms of cancers we know. On average, every day three people die of prostate cancer in Norway alone. Over the length of a year, that number climbs above 5000 and they are all exclusively male.

For 20 years the Pink-Ribbon Campaign has been synonymous with awareness of breast cancer, a form of cancer that almost exclusively affect women. The movement was a success and brought a lot of attention and money for breast cancer research. Now, the attention turns to men and prostate cancer.

Research Needed
— I think we will receive a lot of attention with this campaign. The disease affects so many and is under communicated. Men often keep this type of information to themselves. And importantly, we need more research on the subject, says Anne Lyse Ryel, Secretary General at the Norwegian Cancer Society.

First and foremost, the campaign aims to lift prostate cancer into the limelight. Subsequently lifting taboos and increasing awareness among men and the population at large. Next in line is money for research. It is severely needed because reaching 2030, estimates predict an 40 percent increase on the frequency of prostate cancer.

An Update on Prostate Cancer
However, research is very much ongoing. And, if you are wondering what the most current research on prostate cancer entails? Visit Oslo Cancer Cluster’s R&D Network Meeting that Thursday the 30th of November focuses on exactly prostate cancer research. It can serve as a very informative conclusion to a month of prostate cancer awareness. Listen to prominent experts explaining current research and where prostate cancer research is heading in the future.

Read more about our Prostate Cancer meeting.

Print This Post